Merus N.V. (MRUS)
NASDAQ: MRUS · Real-Time Price · USD
47.21
-1.32 (-2.72%)
Dec 3, 2024, 1:55 PM EST - Market open
Merus Employees
As of December 31, 2023, Merus had 229 total employees, including 172 full-time and 57 part-time employees. The number of employees increased by 8 or 3.62% compared to the previous year.
Employees
229
Change (1Y)
8
Growth (1Y)
3.62%
Revenue / Employee
$156,908
Profits / Employee
-$1,067,930
Market Cap
3.23B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Bausch Health Companies | 20,270 |
Amedisys | 19,000 |
Surgery Partners | 13,500 |
Neogen | 2,917 |
Inari Medical | 1,300 |
Amicus Therapeutics | 517 |
SpringWorks Therapeutics | 305 |
Kymera Therapeutics | 187 |
MRUS News
- 1 day ago - Merus and Partner Therapeutics Announce License Agreement for the U.S. Commercialization of Zenocutuzumab in NRG1 Fusion-Positive Cancer - GlobeNewsWire
- 2 days ago - Merus Announces Publication of an Abstract on Petosemtamab as 2L+ treatment of r/m HNSCC at the ESMO Asia Congress 2024 - GlobeNewsWire
- 26 days ago - Merus to Present at Upcoming Investor Conferences - GlobeNewsWire
- 4 weeks ago - Merus: Petosemtamab Set Up For December 2024 Data Presentation - Seeking Alpha
- 4 weeks ago - Merus Receives FDA extension of PDUFA for zenocutuzumab - GlobeNewsWire
- 4 weeks ago - Merus Announces Financial Results for the Third Quarter 2024 and Provides Business Update - GlobeNewsWire
- 3 months ago - Merus: Great European Oncology Developer, But Properly Valued - Seeking Alpha
- 4 months ago - Merus Announces Financial Results for the Second Quarter 2024 and Provides Business Update - GlobeNewsWire